ENTITY
Moderna

Moderna (MRNA US)

109
Analysis
Health Care • United States
Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
more
bullish•Hang Seng Index
•22 Aug 2026 05:00

Hong Kong Single Stock Options Weekly Aug 17–21: Earnings, Biotech and Rising Option Volumes

Earnings-driven stock moves, rising option activity and renewed interest in Health Care shaped a stronger week across Hong Kong single stocks.

Logo
John Ley
110 Views
Share
•21 Aug 2026 09:22

CanSino Biologics(6185 HK): Price Surged - Worth a Shot !!

CanSino Biologics (6185 HK)  shares surged on the back of Moderna (MRNA US)  breakthroughs with its mRNA vaccine for melanoma. Cansino was China's...

Logo
167 Views
Share
•16 Aug 2023 08:55

China's Extremely Rare Policy to Attract Foreign Investment and the Signals Behind

Attracting foreign investment is commonplace and investors may not realize the importance,but new policy released by the State Council will bring...

Logo
584 Views
Share
•15 Dec 2022 14:11•Syndicated

CX Daily: Chinese Mainlanders Rush to Macao for MRNA Vaccinations

Chinese mainlanders rush to Macao for mRNA vaccinations. Hong Kong readies crypto futures ETFs for retail investors. China calls India border...

Logo
611 Views
Share
•03 Oct 2022 22:07

A Look at How a Portfolio Composed of Our Top Five Innovators in Each Report Would Have Performed

Our datamining reports ranks companies within thematic based on innovation quality. We see strong outperformance in a portfolio built using the top...

Logo
487 Views
Share
x